Prophylactic swallowing therapy for patients with head and neck cancer: A three‐arm randomized parallel‐group trial

SwallowIT provided clinically equivalent outcomes to traditional service models. SwallowIT and clinician-directed therapy were preferred by patients, likely due to higher levels of therapy support.